TO OUR SHAREHOLDERS |
|
FRESENIUS SHARE 2012 |
|
KEY TOPICS 2012 |
|
KEY FIGURES COMPARISON |
2012 marked our 100th anniversary. As a leading global health care group we are dedicated to the advancement of medicine and human health – values we have upheld ever since our founding as a small pharmacy lab in 1912.
more...
|
|
2012 was an extremely successful year on the stock markets, despite the ongoing
financial and debt crisis. The Fresenius share maintained excellent momentum. Its share price
increased steadily and reached a new record level in October.
more...
|
|
100 years of Fresenius
In year 1912, Dr. Eduard Fresenius set the cornerstone of our business. In the laboratory of his Frankfurt pharmacy he started a small pharmaceutical company that became the global health care group Fresenius.
more...
Successful Acquisitions
In 2012, all business segments posted significant organic sales growth, taking advantage of opportunities created by market consolidation. Fresenius Kabi acquired Fenwal Holdings and now enjoys a leading position worldwide in transfusion technology. Fresenius Helios significantly strengthened its hospital network in Northern Germany with the acquisition of the Damp Group.
more...
Summary of the fiscal year
Consolidated sales increased by 18% to €19,290 million and operating income (EBIT) grew by 20% to €3,075 million. The EBIT margin increased to a new record level of 15.9%. Group net income increased by 22% to €938 million and earnings per share by 15% to €5.42.
more...
Strategy and Goals
Our goal is to build Fresenius into a leading global provider of products and therapies for critically and chronically ill people. We are concentrating our business segments on a few health care areas. Thanks to this clear focus, we have developed unique competencies.
more...
Employees
Well-trained and experienced employees are vitally important for our Company’s success. It is largely thanks to their achievements, skills and commitment that all our business segments hold leading positions in their markets.
more...
Outlook
With its international production and sales platform and its market-oriented products and services, the Fresenius Group is well positioned for continued growth in the coming years.
more...
|
|
Use our interactive key figures comparison. Here you can compare individual key figures and show them as graphs.
more...
|